• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » May 2003 – The CenterWatch Monthly : PDF
May 2003 – The CenterWatch Monthly : PDF

May 2003 – The CenterWatch Monthly : PDF

$79.00

Product Details

Voicing Site Hopes and Frustrations with EDC

Investigative sites are highly receptive to the promise of EDC solutions. However, current trials that use EDC technologies appear to be increasing workload, are fraught with technical problems, lack adequate training and support, and often involve paper-based approaches in anticipation of EDC failures. Sponsors and CROs report higher levels of sensitivity to investigative site EDC needs and capabilities. More than 25% of sites report that sponsors are increasing grant amounts to compensate for additional workload. And nearly 60% of sites report that their experience with EDC factors into sponsors’ site selection decisions.

Projecting HIPAA’s Impact

The majority of investigative sites report that they are prepared to be HIPAA compliant under the mandated Privacy Rule. Sites have focused their preparation on personnel training, creating new standard operating procedures and establishing new internal roles and functions. In clinical research, HIPAA is most expected to impact the informed consent process and patient recruitment. Variations in interpreting the HIPAA Privacy Rule are contributing to high levels of uncertainty and confusion that may result in delays and increase the likelihood of HIPAA non-compliance.

Also in this issue:

  • Emerging CRA Specialization in Europe
  • Eye On: Urinary incontinence

 

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing